Literature DB >> 19411564

Germline mutation of microRNA-125a is associated with breast cancer.

W Li1, R Duan, F Kooy, S L Sherman, W Zhou, P Jin.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that inhibit expression of specific target genes at the posttranscriptional level. MiRNAs are often found to be misregulated in human cancer, and they can act as either potent oncogenes or tumour suppressor genes. Here we show that a germline mutation in mature miR-125a is highly associated with breast cancer tumorigenesis, suggesting that miR-125a is likely to function as a tumour suppressor gene in human cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411564     DOI: 10.1136/jmg.2008.063123

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  43 in total

Review 1.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

2.  Mutations in the let-7 binding site - a mechanism of RAS activation in juvenile myelomonocytic leukemia?

Authors:  Doris Steinemann; Marcel Tauscher; Inka Praulich; Charlotte M Niemeyer; Christian Flotho; Brigitte Schlegelberger
Journal:  Haematologica       Date:  2010-05-11       Impact factor: 9.941

Review 3.  Entangling Relation of Micro RNA-let7, miRNA-200 and miRNA-125 with Various Cancers.

Authors:  Nosheen Masood; Zarrin Basharat; Tabeer Khan; Azra Yasmin
Journal:  Pathol Oncol Res       Date:  2017-01-09       Impact factor: 3.201

4.  Association between miR-125a rs12976445 and survival in breast cancer patients.

Authors:  Lianghe Jiao; Jiaxin Zhang; Yuanyuan Dong; Bensong Duan; Hong Yu; Haihui Sheng; Junxing Huang; Hengjun Gao
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

Review 5.  The roles of structural dynamics in the cellular functions of RNAs.

Authors:  Laura R Ganser; Megan L Kelly; Daniel Herschlag; Hashim M Al-Hashimi
Journal:  Nat Rev Mol Cell Biol       Date:  2019-08       Impact factor: 94.444

Review 6.  Small players with big roles: microRNAs as targets to inhibit breast cancer progression.

Authors:  Stephanie B Greene; Jason I Herschkowitz; Jeffrey M Rosen
Journal:  Curr Drug Targets       Date:  2010-09       Impact factor: 3.465

Review 7.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Authors:  Paige E Bennett; Lynne Bemis; David A Norris; Yiqun G Shellman
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

8.  Discovery of microRNAs and other small RNAs in solid tumors.

Authors:  Eti Meiri; Asaf Levy; Hila Benjamin; Miriam Ben-David; Lahav Cohen; Avital Dov; Nir Dromi; Eran Elyakim; Noga Yerushalmi; Orit Zion; Gila Lithwick-Yanai; Einat Sitbon
Journal:  Nucleic Acids Res       Date:  2010-05-18       Impact factor: 16.971

9.  Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.

Authors:  Natalie Goldberger; Renard C Walker; Chang Hee Kim; Scott Winter; Kent W Hunter
Journal:  Cancer Res       Date:  2013-02-27       Impact factor: 12.701

10.  Structural dynamics control the MicroRNA maturation pathway.

Authors:  Paul Dallaire; Huiping Tan; Keith Szulwach; Christopher Ma; Peng Jin; François Major
Journal:  Nucleic Acids Res       Date:  2016-09-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.